データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
91714-93-1Nc1c(CC(=O)[O-])cccc1C(=O)c1ccc(Br)cc1.[Na+]HZFGMQJYAFHESD-UHFFFAOYSA-M91714-93-1DTXSID70273981CHEBI:140536安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
説明Bromfenac Sodium was launched in the US as a potent, orally-active, long lasting peripheral analgesic with antiinflammatory properties. It is structurally similar to ketoprofen and diclofenac and can be prepared in three steps from 2-amino-4’-bromophenone using Gassman’s oxindole synthesis. Duract’s biological effects are a result of its ability to reduce prostaglandin production through inhibition of cyclooxygenase. As a 4-bromo derivative of Amfenac, this modification increased the duration of analgesic activity and antiinflammatory potency. It was also free of any CNS, cardiovascular or autonomic effects. In comparison, 5 mg of Duract was equipotent to 650 mg of ASA and 25 mg was slightly more potent than 400 mg of Ibuprofen.
使用Bromfenac sodium has been used:to study its ability to bind to melaninin the synthesis of bromfenac indolinone standardto analyze its permeability in porcine conjunctiva
定義ChEBI: The sodium salt of bromfenac. Note that 'bromfenac sodium' commonly refers to the sesquihydrate (120638-55-3); this is the anhydrous form.
読み込み中…
読み込み中…
現在のフィルター条件では反応記録がありません。
読み込み中…